Meridiam Announces Tender Offer to Acquire Allego N.V

 European electric vehicle charging company Allego N.V. (ALLG) announced on June 17, 2024, that it entered into an agreement under which Meridiam will launch a tender offer for Allego, valued at $1.46 billion.

Deal Structure:

According to the agreement, Meridiam will offer Allego shareholders the option to tender their shares for $1.70 per share in cash, representing a premium of 131.29% to Allego’s last closing price as of June 14, 2024.

Company Profile:

Allego is a leading electric vehicle charging solutions provider founded in 2013 and publicly listed on the NYSE in 2022. It offers a comprehensive portfolio of innovative charging infrastructure and software across 35,000 charging points in 16 countries, utilizing 100% renewable energy.

Allego went public through a merger with a blank-check firm, Spartan Acquisition Corp III, backed by private equity giant Apollo Global Inc (APO).

Meridiam, which has invested in Allego since 2018, is an independent investment Benefit Corporation and asset manager founded in 2005 by Thierry Déau, specializing in sustainable infrastructure, managing over US$22 billion across 125 projects globally.

Deal Details and Timeline:

Following the completion of the tender offer, expected in the third quarter of 2024, Allego will be delisted from the New York Stock Exchange.

Allego’s current Price/Sales (TTM) ratio is 0.65, below the sector median of 0.84.

The shareholders who choose not to tender their ordinary shares will remain investors in the delisted company.

Deal Metrics:

To explore more about this M&A transaction, please visit the Deal Metrics page here:

Deal Metrics for the acquisition of Allego N.V. (ALLG) by Meridiam.

The Deal Metrics page for each merger or acquisition includes:

  • A spread history chart of the merger from announcement through eventual completion or failure.
  • Every event as the merger progresses through the expiration of the HSR period, various regulatory approvals, shareholder votes, etc.
  • News and SEC filings.
  • A history of deal updates.
  • And a whole lot more.
Disclaimer: Please do your own due diligence before buying or selling any securities mentioned in this article. We do not warrant the completeness or accuracy of the content or data provided in this article.

Comments

Post a Comment

Popular posts from this blog

Darden's Bold Move: Acquiring Chuy's for a Flavorful Future

  In the latest shake-up in the restaurant industry, Darden Restaurants, Inc. has announced its acquisition of Chuy's Holdings, Inc . This merger is set to create a powerhouse in the casual dining sector, bringing together two beloved brands under one corporate roof. Here’s what you need to know about this exciting development. Chuy’s Holdings Inc. ( CHUY ):  $37.08 Market Cap:  $643.38 M Deal Size:  $605 M Back in 2014, a heated battle between Darden Restaurants  (DRI)  and the activist hedge fund Starboard Value brought to light some surprising inefficiencies within Darden’s flagship chain, Olive Garden. In an attempt to win control of Darden’s board, Starboard pointed out not only the wastefulness of unlimited breadsticks at Olive Garden but also its puzzling decision to stop salting its pasta water as “adding salt to the boiling water could jeopardize warranties on pots”. These small yet significant details became symbols of the broader issues w...
Read more

Inside the $5.1 Billion Deal: Sixth Street’s Strategic Acquisition of Enstar Group

  Enstar Group Limited (NASDAQ: ESGR) recently became the focal point of investor discussions as Sixth Street Partners announced its acquisition for approximately $5.1 billion. This acquisition has piqued interest not only due to its substantial value but also because of the involvement of notable figures such as former Treasury Secretary Steven Mnuchin and billionaire investor J. Christopher Flowers. Deal Overview In a market where mergers and acquisitions often make headlines, Sixth Street’s acquisition of Enstar Group stands out. Enstar, an insurer with a market cap of $4.97 billion, caught the eye of Sixth Street, an investment firm that already held a 4% stake in the company. The terms of the agreement are straightforward: Sixth Street will pay Enstar shareholders $338.00 in cash per ordinary share. This price represents a 2.96% discount from Enstar's last closing price of $326.91 and offers a 5.5% premium over the 30-day average price. Market Reaction Following the a...
Read more

Strategic Biopharma Merger: Pharmacosmos to Acquire G1 Therapeutics in $405M Deal

  In the ever-evolving landscape of the biopharmaceutical industry, strategic acquisitions and mergers are critical for companies looking to bolster their portfolios and expand their global reach. Last week, we witnessed a noteworthy development as G1 Therapeutics Inc. (NASDAQ: GTHX) became the latest target in a high-profile acquisition by Pharmacosmos A/S, a Denmark-based company renowned for its expertise in carbohydrate chemistry and treatments for iron deficiency and anemia. Read More Info @ https://www.insidearbitrage.com/2024/08/g1-therapeutics-attracts-a-danish-suitor-merger-arbitrage-mondays/ The Deal in Detail Pharmacosmos, through its U.S. subsidiary Pharmacosmos Therapeutics Inc., has entered into a definitive merger agreement to acquire G1 Therapeutics for a total deal size of approximately $405 million. This transaction represents a significant premium over G1's market value, offering $7.15 per share in cash, which is a substantial 68.24% premium over G1’s las...
Read more